Clinical diagnosis and treatment of immune checkpoint inhibitors‐related endocrine dysfunction
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical diagnosis and treatment of immune checkpoint inhibitors‐related endocrine dysfunction
Authors
Keywords
-
Journal
Thoracic Cancer
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-02-11
DOI
10.1111/1759-7714.13347
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
- (2019) Filipe Martins et al. Nature Reviews Clinical Oncology
- The Changing Clinical Spectrum of Hypophysitis
- (2019) Sabrina Chiloiro et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- High-dose glucocorticoids for the treatment of ipilimumab-induced hypophysitis is associated with reduced survival in patients with melanoma
- (2018) Alexander T. Faje et al. CANCER
- Endocrine dysfunction induced by immune checkpoint inhibitors: Practical recommendations for diagnosis and clinical management
- (2018) Romualdo Barroso-Sousa et al. CANCER
- IPILIMUMAB-INDUCED SECONDARY HYPOPHYSITIS
- (2018) Arvinder Cheema Endocrine Practice
- SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Acute management of the endocrine complications of checkpoint inhibitor therapy
- (2018) C E Higham et al. Endocrine Connections
- Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens
- (2018) Romualdo Barroso-Sousa et al. JAMA Oncology
- Endocrine and metabolic adverse effects of immune checkpoint inhibitors: an overview (what endocrinologists should know)
- (2018) R. M. Ruggeri et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Hypothyroidism in Cancer Patients on Immune Checkpoint Inhibitors with anti-PD1 Agents: Insights on Underlying Mechanisms
- (2017) M. Alhusseini et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Characterization of Thyroid Disorders in Patients Receiving Immune Checkpoint Inhibition Therapy
- (2017) Hyunju Lee et al. Cancer Immunology Research
- Hypophysitis Secondary to Cytotoxic T-Lymphocyte–Associated Protein 4 Blockade
- (2016) Patrizio Caturegli et al. AMERICAN JOURNAL OF PATHOLOGY
- Immune checkpoint inhibitor-related hypophysitis and endocrine dysfunction: clinical review
- (2016) M.N Joshi et al. CLINICAL ENDOCRINOLOGY
- Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline
- (2016) Maria Fleseriu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Immune Checkpoint Inhibitors: Review and Management of Endocrine Adverse Events
- (2016) Elisa González-Rodríguez et al. ONCOLOGIST
- Systemic High-Dose Corticosteroid Treatment Does Not Improve the Outcome of Ipilimumab-Related Hypophysitis: A Retrospective Cohort Study
- (2014) L. Min et al. CLINICAL CANCER RESEARCH
- Ipilimumab-Induced Hypophysitis: A Detailed Longitudinal Analysis in a Large Cohort of Patients With Metastatic Melanoma
- (2014) Alexander T. Faje et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Endocrine Side Effects Induced by Immune Checkpoint Inhibitors
- (2013) Salvatore Maria Corsello et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started